Pharmaceutical combination

US10206890B2 · kind B2 · utility

Assignee

• Gruenenthal GmbH · DE

Inventors

• Klaus Schiene · Goldkronach, DE
• Petra Bloms-Funke · Harsewinkel, DE
• Thomas Christoph · Aachen, DE

Key dates

• Filing date: Oct 30, 2015
• Grant date: Feb 19, 2019
• Expiry date: Oct 30, 2035

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P29/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A composition of matter comprising in combination as component (a) at least one 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol compound, and as component (b) at least one antiepileptic, a pharmaceutical formulation and a dosage form comprising said composition of matter, and a method of treating pain, e.g. neuropathic pain, in which components (a) and (b) are administered simultaneously or sequentially to a mammal, whereby component (a) may be administered before or after component (b) and whereby components (a) or (b) are administered to the mammal either via the same or a different pathway of administration.